4CMenB Breadth of Immune Response, Immunogenicity, and Safety: Results From a Phase 3 Randomized, Controlled, Observer Blind Study in Adolescents and Young Adults

QUINTET study group, Terry Nolan, Chiranjiwi Bhusal, Jiří Beran, Mark Bloch, Benhur S Cetin, Ener C Dinleyici, Daniel Dražan, Satu Kokko, Susanna Koski, Outi Laajalahti, Joanne M Langley, Mika Rämet, Peter C Richmond, Peter Silas, Bruce Tapiero, Florence Tiong, Mary Tipton, Benita Ukkonen, Betul UlukolMaria Lattanzi, Mauro Trapani, Arnold Willemsen, Daniela Toneatto

Research output: Contribution to journalArticleScientificpeer-review

1 Citation (Scopus)
2 Downloads (Pure)

Fingerprint

Dive into the research topics of '4CMenB Breadth of Immune Response, Immunogenicity, and Safety: Results From a Phase 3 Randomized, Controlled, Observer Blind Study in Adolescents and Young Adults'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases